NCM

Nantahala Capital Management Portfolio holdings

AUM $1.41B
1-Year Return 32.9%
This Quarter Return
-1.49%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.69B
AUM Growth
-$119M
Cap. Flow
-$7.71M
Cap. Flow %
-0.46%
Top 10 Hldgs %
41.68%
Holding
139
New
23
Increased
20
Reduced
48
Closed
15

Top Buys

1
IWM icon
iShares Russell 2000 ETF
IWM
$21.8M
2
SMLR icon
Semler Scientific
SMLR
$18.2M
3
TSHA icon
Taysha Gene Therapies
TSHA
$15.2M
4
IMAX icon
IMAX
IMAX
$11.9M
5
FTCV
FinTech Acquisition Corp. V Class A Common Stock
FTCV
$10M

Top Sells

1
VG
Vonage Holdings Corporation
VG
$21M
2
LNW icon
Light & Wonder
LNW
$18M
3
PWP icon
Perella Weinberg Partners
PWP
$13.6M
4
FTCVU
FinTech Acquisition Corp. V Unit
FTCVU
$13.1M
5
HOME
At Home Group Inc.
HOME
$10.5M

Sector Composition

1 Healthcare 45.09%
2 Consumer Discretionary 15.64%
3 Technology 9.17%
4 Financials 7.85%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RMR icon
26
The RMR Group
RMR
$284M
$21M 0.66%
626,751
-34,233
-5% -$1.15M
CRIS icon
27
Curis
CRIS
$21M
$19.3M 0.61%
123,112
+18,935
+18% +$2.97M
AUTL
28
Autolus Therapeutics
AUTL
$389M
$19.2M 0.61%
2,936,791
+1,143,291
+64% +$7.49M
SMLR icon
29
Semler Scientific
SMLR
$416M
$18.2M 0.57%
+145,419
New +$18.2M
RDI icon
30
Reading International Class A
RDI
$33.8M
$17.6M 0.55%
3,470,315
+1,153,576
+50% +$5.84M
PAYA
31
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$16.1M 0.51%
1,481,096
-13,020
-0.9% -$142K
DHX icon
32
DHI Group
DHX
$143M
$16.1M 0.51%
3,375,606
-403,294
-11% -$1.92M
APTO
33
DELISTED
Aptose Biosciences, Inc.
APTO
$16M 0.51%
16,346
-413
-2% -$405K
AKU
34
DELISTED
Akumin Inc. Common Stock (DE)
AKU
$15.7M 0.49%
6,320,740
+100,000
+2% +$248K
AVTX icon
35
Avalo Therapeutics
AVTX
$153M
$15.2M 0.48%
2,414
+218
+10% +$1.37M
BBQ
36
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$15.1M 0.48%
1,000,000
– –
DRIO icon
37
DarioHealth
DRIO
$23M
$14.5M 0.46%
53,176
– –
AKBA icon
38
Akebia Therapeutics
AKBA
$785M
$14.3M 0.45%
4,978,195
-191,868
-4% -$553K
SPRY icon
39
ARS Pharmaceuticals
SPRY
$995M
$12.2M 0.39%
1,226,631
-39,635
-3% -$396K
SYRE icon
40
Spyre Therapeutics
SYRE
$1.03B
$12.1M 0.38%
60,678
-6,403
-10% -$1.27M
STR
41
DELISTED
Sitio Royalties
STR
$11.7M 0.37%
623,728
-32,959
-5% -$620K
FTCV
42
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
$10M 0.32%
+991,432
New +$10M
FTVIU
43
DELISTED
FinTech Acquisition Corp. VI Units
FTVIU
$10M 0.32%
1,000,000
– –
GYRE icon
44
Gyre Therapeutics
GYRE
$698M
$10M 0.32%
324,295
-13,220
-4% -$407K
ARYE
45
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$9.88M 0.31%
+1,000,000
New +$9.88M
IIII
46
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
$9.82M 0.31%
+999,996
New +$9.82M
HERA
47
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$9.74M 0.31%
+999,991
New +$9.74M
LINC icon
48
Lincoln Educational Services
LINC
$613M
$9.6M 0.3%
1,434,674
-23,534
-2% -$157K
SLNO icon
49
Soleno Therapeutics
SLNO
$3.71B
$9.03M 0.28%
651,009
– –
HCA icon
50
HCA Healthcare
HCA
$98.5B
$8.64M 0.27%
35,600
– –
1
2
3 4 5